Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05134142 · ClinicalTrials.gov registry record

Quality of Life and Function of Patients With Pelvic Tumors After Undergoing Hemipelvectomy

A clinical trial of Malignant Primary Pelvic Neoplasm, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
200
Enrollment target
1
Study location

NCT05134142 is a study of Malignant Primary Pelvic Neoplasm that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05134142, a study of Malignant Primary Pelvic Neoplasm, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
200 participants
Enrollment target
1
Study location

Study Summary

This study aims to determine the functional outcomes of patients who underwent internal hemipelvectomy with or without reconstruction or external hemipelvectomy for pelvic tumors. Learning about the outcomes of these patients may help researchers determine the long-term effects of different types of hemipelvectomy procedures and may help improve quality of life.

Interventions

  • OTHER Quality-of-Life Assessment
  • OTHER Questionnaire Administration
  • OTHER Electronic Health Record Review
  • OTHER Physical Performance Testing

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2013-03-27
Est. Completion 2027-04-30

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT05134142

The ClinicalTrials.gov registry entry for NCT05134142 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Malignant Primary Pelvic Neoplasm appearing as the primary indexed condition, and to 4 interventions - of which Quality-of-Life Assessment is the first listed.

NCT05134142 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05134142 about?

NCT05134142 is a clinical study titled "Quality of Life and Function of Patients With Pelvic Tumors After Undergoing Hemipelvectomy". This study aims to determine the functional outcomes of patients who underwent internal hemipelvectomy with or without reconstruction or external hemipelvectomy for pelvic tumors. Learning about the outcomes of these patients may help researchers determine the long-term effects of different types of...

What is the current status of trial NCT05134142?

This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2013-03-27. Estimated completion is 2027-04-30.

What conditions does trial NCT05134142 study?

This clinical trial studies the following conditions: Malignant Primary Pelvic Neoplasm.

What interventions are being tested in trial NCT05134142?

The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Electronic Health Record Review (OTHER), Physical Performance Testing (OTHER).

Who is sponsoring clinical trial NCT05134142?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05134142 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.